Power and sample size considerations in clinical trials with competing risk endpoints

2006 ◽  
Vol 5 (3) ◽  
pp. 159-171 ◽  
Author(s):  
Ellen Maki
1990 ◽  
Vol 29 (03) ◽  
pp. 243-246 ◽  
Author(s):  
M. A. A. Moussa

AbstractVarious approaches are considered for adjustment of clinical trial size for patient noncompliance. Such approaches either model the effect of noncompliance through comparison of two survival distributions or two simple proportions. Models that allow for variation of noncompliance and event rates between time intervals are also considered. The approach that models the noncompliance adjustment on the basis of survival functions is conservative and hence requires larger sample size. The model to be selected for noncompliance adjustment depends upon available estimates of noncompliance and event rate patterns.


Trials ◽  
2008 ◽  
Vol 9 (1) ◽  
Author(s):  
David M Kent ◽  
Alawi Alsheikh-Ali ◽  
Rodney A Hayward

2021 ◽  
Author(s):  
L. Howells ◽  
S. Gran ◽  
J. R. Chalmers ◽  
B. Stuart ◽  
M. Santer ◽  
...  

1994 ◽  
Vol 13 (8) ◽  
pp. 859-870 ◽  
Author(s):  
Robert P. McMahon ◽  
Michael Proschan ◽  
Nancy L. Geller ◽  
Peter H. Stone ◽  
George Sopko

2014 ◽  
Vol 56 (4) ◽  
pp. 614-630 ◽  
Author(s):  
Alexandra C. Graf ◽  
Peter Bauer ◽  
Ekkehard Glimm ◽  
Franz Koenig

Stroke ◽  
2009 ◽  
Vol 40 (7) ◽  
pp. 2362-2367 ◽  
Author(s):  
Kurt T. Kreiter ◽  
Stephan A. Mayer ◽  
George Howard ◽  
Volker Knappertz ◽  
Don Ilodigwe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document